Cargando…
Network Pharmacology and Pharmacological Mechanism of CV-3 in Atrial Fibrillation
The high fatality and disability rate of atrial fibrillation (AF) strongly promote the development of pathogenesis and treatment of AF that is of great value. The present research attempted to clarify potential mechanisms of Mujiangzi oil (CV-3) in treating AF by constructing an AF cardiomyocytes mo...
Autores principales: | Wang, Zundong, Zeng, Zhen, Hu, Yongsheng, Sun, Hengcan, Tang, Ying, Liu, Weiqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213136/ https://www.ncbi.nlm.nih.gov/pubmed/35747377 http://dx.doi.org/10.1155/2022/5496299 |
Ejemplares similares
-
Mitochondrial Dysfunction in Atrial Fibrillation—Mechanisms and Pharmacological Interventions
por: Muszyński, Paweł, et al.
Publicado: (2021) -
Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006) -
Non-pharmacological Treatment of Atrial Fibrillation
por: Anfinsen, Ole-Gunnar
Publicado: (2002) -
Clinical Pharmacology of Chronic Atrial Fibrillation
por: Lewis, Richard, et al.
Publicado: (1988) -
Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation
por: Ueberham, Laura, et al.
Publicado: (2017)